First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, PUblished by Amazentis and Researchers From the EPFL and SIB

LAUSANNE, Switzerland–(BUSINESS WIRE)– Amazentis, an innovative life sciences company pioneering scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in Nature Metabolism with scientists at the École Polytechnique Fédérale de Lausanne (EPFL) and…

Visit Us On TwitterVisit Us On Google PlusVisit Us On LinkedinVisit Us On Facebook